AIDS 2012 plenary speakers call for innovative financing, continued research for HIV cure

NewsGuard 100/100 Score

Speakers at Tuesday's plenary session at the XIX International AIDS Conference in Washington, D.C. highlighted the challenges that lie ahead in the response to HIV/AIDS and discussed potential solutions, ABC News reports (Duwell, 7/25). Bernhard Schwartlander, director for evidence, strategy and results at UNAIDS, "highlighted the many new possibilities for collaboration, activism, and financing for the AIDS response as economic growth is rapidly changing the global order," UNAIDS reports in a feature story (7/24). "A lot of very clever and dedicated people are working very hard in making sure that services are delivered more efficiently, and ... more people receive HIV services with the same amount of money," he said at the session, PlusNews writes (7/25). According to UNAIDS, Schwartlander "outlined a number of innovative financing methods ... such as the financial transaction tax; front-loading investments for health through bonds; or utilizing fines paid by pharmaceutical companies for anti-competitive practices for health assistance" (7/24).

Also speaking at the plenary session on Tuesday, Javier Martinez-Picado with Spain's IrsiCaixa AIDS Research Institute discussed the possibility of finding a cure for AIDS, saying "that even though he does not expect a cure anytime soon, researchers see hope for one," VOA News notes. "Yet, Martinez-Picado said he foresees several more years of laboratory research to advance basic science knowledge before considering clinical trials," ABC News writes. U.S. Assistant Secretary for Health Howard Koh opened the session with a speech about the National HIV/AIDS Strategy (.pdf) (7/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication